跳至主要内容
临床试验/NCT03409315
NCT03409315Unknown不适用

Prospective Evaluation of impRoving Fluoroquinolone Exposure Using Centralized Tdm in TB Patients

University Medical Center Groningen13 个研究点 分布在 13 个国家目标入组 360 人开始时间: 2018年2月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
360
试验地点
13
主要终点
Feasibility of centralized TDM

研究概览

简要总结

Observational, multi-centre, prospective study to investigate the feasibility of centralized TDM of moxifloxacin and levofloxacin in MDR-TB patients by determining turn-around time between sampling and receiving dosing advice.

In addition, the effect of TDM will be evaluated by comparing treatment results of prospective patients receiving TDM with historical controls without TDM.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pulmonary MDR-TB
  • Sputum smear and sputum culture positive at baseline
  • Oral administration of either moxifloxacin or levofloxacin
  • Written informed consent (for use of the medical data)

排除标准

  • Pregnancy or breast feeding

结局指标

主要结局

Feasibility of centralized TDM

时间窗: 1 week

Turn-around time between plasma sampling and receiving dosing advice

次要结局

  • Impact of centralized TDM(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan-Willem C Alffenaar

PhD, PharmD

University Medical Center Groningen

研究点 (13)

Loading locations...

相似试验